SLXN Silexion Therapeutics Corp - Ordinary Shares

NASDAQ · Biotechnology · View on SEC EDGAR ↗
$2.65
Price · Jul 2, 2026
Fundamentals as of May 19, 2026
52W Range
$0–$22
11% of range
Analyst Rating
BUY
8 analysts
Price Target
$60
+2168% upside
P/E (TTM)
0.2
ROE
—
Net Profit Margin
—

SLXN Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

Price
$2.65
Market Cap
—
P/E (TTM)
0.2
EPS (TTM)
—
Revenue (TTM)
—
Div Yield
—
ROE
—
Debt/Equity
—
52W Range
$0 – $22

SLXN Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

10-Year Performance Revenue, net income, margins and EPS trends

Revenue & Net Income —
EPS —
Free Cash Flow —
Margins —

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric
5Y trend
SLXN
Peer Median
P/E (TTM)
0.2
—

Profitability Gross, operating and net margins; ROE, ROA, ROIC

Metric
5Y trend
SLXN
Peer Median

Financial Health Debt, liquidity, solvency — balance sheet strength

Metric
5Y trend
SLXN
Peer Median

Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR

Metric
5Y trend
SLXN
Peer Median

Per Share Metrics EPS, book value per share, cash flow per share, dividend per share

Metric
5Y trend
SLXN
Peer Median

Capital Efficiency Asset turnover, inventory turnover, receivables turnover

Metric
5Y trend
SLXN
Peer Median

SLXN Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

BUY 8 analysts
  • Strong Buy 2 25.0%
  • Buy 5 62.5%
  • Hold 1 12.5%
  • Sell 0 0.0%
  • Strong Sell 0 0.0%

12-Month Price Target

2 analysts · 2026-07-02
Median target $60.00 +2168.4%
Mean target $60.00 +2168.4%

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

Avg Surprise
-49.2%
Period EPS Actual EPS Est Surprise
March 31, 2026 $-8.50 $-13.16 4.7%
Dec. 31, 2025 $-14.00 $-11.42 -2.6%
Sept. 30, 2025 $-28.80 $-34.68 5.9%
June 30, 2025 $-43.20 $-36.72 -6.5%
March 31, 2025 $-3.90 $-3.37 -0.53%
Dec. 31, 2024 $-311.40 $-14.99 -296.4%

Peer Comparison Key metrics vs sector peers

Ticker Market Cap P/E Rev YoY Net Margin ROE Gross Margin
SLXN — 0.2 — — — —
EVGN — — — — — —
CLGN — — — — — —
GLMD — — — — — —
SCNI — — — — — —
URGN $1.13B — 21.4% -139.8% 154.4% 88.7%

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

Balance Sheet 16
Annual Balance Sheet data for SLXN
Metric Trend 2025
Cash & Equivalents $6M
Prepaid Expense $570.0K
Other Current Assets $49.0K
Current Assets $7M
PP&E (Net) $25.0K
Total Assets $7M
Accrued Liabilities $859.0K
Current Liabilities $3M
Capital Leases $286.0K
Total Liabilities $5M
Common Stock $42.0K
Paid-in Capital $58M
Retained Earnings $-55M
Stockholders' Equity $3M
Liabilities + Equity $7M
Shares Outstanding 3,126,651
Per Share 1
Annual Per Share data for SLXN
Metric Trend 2025
EPS (TTM) $8.96
Valuation (TTM) 3
Annual Valuation (TTM) data for SLXN
Metric Trend 2025
Net Income TTM $-12M
P/E 0.2
Earnings Yield 466.7%

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

My Metrics Your personal watchlist — selected rows from Full Fundamentals

📊

Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.